[Taiwan Medical] Announcement of Company's Consolidated Financial Report for Q1 115
Key facts
- [Taiwan Medical] Announcement of Company's Consolidated Financial Report for Q1 115
- Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The company reported operating revenue of NT$45.422 million, with a net loss of NT$15.252 million and basic EPS of NT$0.1.
- Source: PR Times
- Date: May 11, 2026
Direct answer
Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The company reported operating revenue of NT$45.422 million, with a net loss of NT$15.252 million and basic EPS of NT$0.1.
- Citation
- [Taiwan Medical] Announcement of Company's Consolidated Financial Report for Q1 115 (May 11, 2026), PR Times
- Source
- PR Times
- Date
- May 11, 2026
Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The company reported operating revenue of NT$45.422 million, with a net loss of NT$15.252 million and basic EPS of NT$0.1.
📋 Article Processing Timeline
- 📰 Published: May 11, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 21:40 (13h 40m after Collected)
1. Date of Board Report or Board Resolution: 115/05/11
2. Date of Audit Committee Approval: 115/05/11
3. Financial Reporting Period (Start Date ~ End Date): 115/01/01~115/03/31
4. Cumulative Operating Revenue from Jan 1 to Current Period (Thousands of NTD): 45,422
5. Cumulative Gross Profit (or Loss) from Jan 1 to Current Period (Thousands of NTD): 39,489
6. Cumulative Operating Profit (or Loss) from Jan 1 to Current Period (Thousands of NTD): (10,650)
7. Cumulative Profit Before Tax (or Loss) from Jan 1 to Current Period (Thousands of NTD): (14,997)
8. Cumulative Net Profit (or Loss) for the Period from Jan 1 to Current Period (Thousands of NTD): (15,252)
9. Cumulative Net Profit (or Loss) Attributable to Owners of the Parent Company from Jan 1 to Current Period (Thousands of NTD): (15,263)
10. Cumulative Basic Earnings Per Share (Loss) from Jan 1 to Current Period (NTD): (0.1)
11. Total Assets at End of Period (Thousands of NTD): 2,030,443
12. Total Liabilities at End of Period (Thousands of NTD): 588,640
13. Equity Attributable to Owners of the Parent Company at End of Period (Thousands of NTD): 1,441,242
14. Other Matters to Note: None
2. Date of Audit Committee Approval: 115/05/11
3. Financial Reporting Period (Start Date ~ End Date): 115/01/01~115/03/31
4. Cumulative Operating Revenue from Jan 1 to Current Period (Thousands of NTD): 45,422
5. Cumulative Gross Profit (or Loss) from Jan 1 to Current Period (Thousands of NTD): 39,489
6. Cumulative Operating Profit (or Loss) from Jan 1 to Current Period (Thousands of NTD): (10,650)
7. Cumulative Profit Before Tax (or Loss) from Jan 1 to Current Period (Thousands of NTD): (14,997)
8. Cumulative Net Profit (or Loss) for the Period from Jan 1 to Current Period (Thousands of NTD): (15,252)
9. Cumulative Net Profit (or Loss) Attributable to Owners of the Parent Company from Jan 1 to Current Period (Thousands of NTD): (15,263)
10. Cumulative Basic Earnings Per Share (Loss) from Jan 1 to Current Period (NTD): (0.1)
11. Total Assets at End of Period (Thousands of NTD): 2,030,443
12. Total Liabilities at End of Period (Thousands of NTD): 588,640
13. Equity Attributable to Owners of the Parent Company at End of Period (Thousands of NTD): 1,441,242
14. Other Matters to Note: None
FAQ
What are the key facts in this article?
Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The company reported operating revenue of NT$45.422 million, with a net loss of NT$15.252 million and basic EPS of NT$0.1.
What is the direct answer?
Taiwan Medical announced its consolidated financial report for the first quarter of 2026. The company reported operating revenue of NT$45.422 million, with a net loss of NT$15.252 million and basic EPS of NT$0.1.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-6838-2026-05-11-2b9c8d7f | May 11, 2026